Brief: MIRA Pharmaceuticals Secures Worldwide Exclusive Rights To MIRA-55 And SKNY-1 - SEC Filing
04/06/2026 13:06
BRIEF-MIRA Pharmaceuticals Secures Worldwide Exclusive Rights To MIRA-55 And SKNY-1 - SEC Filing June 4 (Reuters) - Mira Pharmaceuticals Inc MIRA.O:
MIRA PHARMACEUTICALS - SECURES WORLDWIDE EXCLUSIVE RIGHTS TO MIRA-55 AND SKNY-1 - SEC FILING
MIRA PHARMACEUTICALS INC: CONTROLS GLOBAL DEVELOPMENT RIGHTS ACROSS ENTIRE PIPELINE
Source text: [ID:n0001493152-26-027202]
Further company coverage: MIRA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mira Pharmaceuticals
See all newsBrief: Mira Pharmaceuticals - Alan Weichselbaum To Step Down As CFO Effective June 6, 2026 - SEC Filing
Brief: MIRA Pharmaceuticals Secures Worldwide Exclusive Rights To MIRA-55 And SKNY-1 - SEC Filing
Brief: Mira Pharmaceuticals Enters Into Amendment No 1 To Exclusive License Agreement With Miralogx
Brief: Mira Pharmaceuticals Inc - Completes Phase 1 Dosing Of Ketamir-2 - SEC Filing
Brief: Mira Pharmaceuticals Inc - Initiates Phase 1 Study Of Ketamir-2 - SEC Filing